Description
EGF was first discovered in the United States by Dr, Stanley Cohen, who was awarded a Nobel Prize in Physiology in 1986. EGF is widely accepted for promoting the regeneration and growth of cells, and the synthesis of collagen. Hyaluronate is hygroscopic, promotes water absorption and provides moisture to the skin. Our recent bioimaging study has visualized that HA-protein conjugate can efficiently penetrate into deep dermal tissues without any additives or devices. PHI-EGF using HA-EGF conjugate was developed to deliver EGF efficiently into deep dermal tissues. PHI-EGF is based on HA-EGF conjugate which is registered in the International Nomenclature of Cosmetic Ingredients (INCI). PHI-EGF has been launched as a serum and an essence. PHI-EGF provides moisture to your skin and prevents aging by promoting regeneration with anti-inflammation effects. PHI-EGF increases the skin density and skin thickness, and is also eective for increasing skin elasticity. The safety of HA-EGF conjugate was confirmed by GLP-certified CRO of ChemOn Inc. and the clinical applicability of PHI-EGF as a cosmedical was confirmed by the dermatology research institute of Ellead Co. The positive effect of PHI-EGF on skin rejuvenation was confirmed by Wonjin Aesthetic Surgery Clinic.